BIA Spotlight: how Stablepharma is pioneering the world’s first fridge-free Td vaccine

Following a number of ‘firsts’ for Stablepharma during 2024, we spoke with Ozgur Tuncer, CEO & Executive Director about a year that has accelerated the commercialisation of the world’s first fridge-free vaccine, SPVX02, for the prevention of Tetanus and Diphtheria. Ozgur also highlights some of the global challenges associated with the cold chain and talks […]

Read More
SPVX02 Fridge-free Td vaccines

Stablepharma Receives MHRA Approval for Phase 1 Trial of Fridge-Free Tetanus & Diphtheria (Td) Vaccine

Stablepharma’s Fridge-Free Vaccine that Eliminates the Need for Cold Chain entering First-in-Human UK Clinical Trial. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for Stablepharma to begin a Phase I clinical trial with SPVX02, an adult booster vaccine aimed at preventing tetanus and diphtheria (Td) infections. This approval marks a major […]

Read More